Semaglutide (Ozempic, Wegovy, and Rybelsus) is a GLP-1 receptor agonist that promotes weight loss and blood sugar control by occupying glucagon-like peptide-1 receptors
Half-unit syringes for precise microdosing Standard insulin syringes mark in 1-unit increments
Monlunabant is an investigational inverse agonist of the CB1 receptor which plays an important role in metabolism and appetite regulation in the central nervous system as well as in peripheral tissues such as adipose tissues, the gastrointestinal tract, kidneys, liver, pancreas, muscles and lungs
Keep Accountability in Place A recent analysis presented at the 2025 American Diabetes Association conference found that patients who maintained monthly check-ins with their care team regained significantly less weight than those who stopped follow-up visits
Preference for oral medication : Ideal for those who prefer pills over injections
"Wegovy (semaglutide) Prescribing Information." 2026